Dialysate Composition for Hemodialysis: Changes and Changing Risk
- PMID: 28066927
- PMCID: PMC7645386
- DOI: 10.1111/sdi.12573
Dialysate Composition for Hemodialysis: Changes and Changing Risk
Abstract
Dialysate composition is a critical aspect of the hemodialysis prescription. Despite this, trial data are almost entirely lacking to help guide the optimal dialysate composition. Often, the concentrations of key components are chosen intuitively, and dialysate composition may be determined by default based on dialysate manufacturer specifications or hemodialysis facility practices. In this review, we examine the current epidemiological evidence guiding selection of dialysate bicarbonate, calcium, magnesium, and potassium, and identify unresolved issues for which pragmatic clinical trials are needed.
© 2017 Wiley Periodicals, Inc.
References
-
- Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 64:1031–40, 2004 - PubMed
-
- Kopple JD, Kalentar-Zadeh K, Mehotra R. Risks of chronic metabolic acidosis in patients with chronic kidney disease. Kidney Int 67(Suppl 95): S21–S28, 2005 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical